Why is Welcure Drugs falling/rising?

As of 17-Nov, Welcure Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 0.58, which reflects a decrease of 0.03 or 4.92%. The stock has underperformed its sector by 5.2% today and has been on a downward trend for the past two days, with a total decline of 9.38% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased significantly, falling by 34.63% compared to the 5-day average, suggesting a reduction in investor participation. There is no information available regarding positive or negative factors that could influence the stock's movement.
In the broader market context, the stock's performance over the past week shows a modest gain of 1.75%, which is slightly better than the Sensex's increase of 1.69%. However, over the longer term, Welcure Drugs has significantly underperformed, with a year-to-date decline of 44.78% compared to the Sensex's gain of 8.72%. This stark contrast highlights the challenges faced by the company relative to the overall market, contributing to the negative sentiment surrounding its stock price.